⌘K
Loading ticker…
Sana Biotechnology, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Sana Biotechnology, Inc. Common Stock (SANA) has a 3-month relative strength percentile of 62 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.6%, relative volume 2.61×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
62 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
SANA is held by 6 ETFs as of Mar 2026. Top owner: XBI at 0.26% weight, $19M notional. Top 3 carry $47M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.26% | $19M |
| VTIVanguard Total Stock Market ETF | 0.00% | $16M |
| IWMiShares Russell 2000 ETF | 0.02% | $12M |
| VXFVanguard Extended Market ETF | 0.01% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $715K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $474K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SANA Jan avg: 39.10% median: 25.00% win: 100% σ: 40.46% n: 4 2022-04-12 → 2026-05-29 | SANA Feb avg: 9.86% median: -11.96% win: 25% σ: 49.14% n: 4 2022-04-12 → 2026-05-29 | SANA Mar avg: -19.63% median: -21.25% win: 0% σ: 16.79% n: 4 2022-04-12 → 2026-05-29 | SANA Apr avg: 13.20% median: 13.10% win: 60% σ: 29.96% n: 5 2022-04-12 → 2026-05-29 | SANA May avg: -4.08% median: 0.30% win: 60% σ: 20.09% n: 5 2022-04-12 → 2026-05-29 | SANA Jun avg: 5.74% median: 12.17% win: 50% σ: 25.28% n: 4 2022-04-12 → 2026-05-29 (current) | SANA Jul avg: 15.62% median: 7.71% win: 75% σ: 22.72% n: 4 2022-04-12 → 2026-05-29 | SANA Aug avg: -8.01% median: -4.68% win: 25% σ: 11.97% n: 4 2022-04-12 → 2026-05-29 | SANA Sep avg: -13.70% median: -19.78% win: 25% σ: 21.52% n: 4 2022-04-12 → 2026-05-29 | SANA Oct avg: -0.82% median: -9.60% win: 25% σ: 28.10% n: 4 2022-04-12 → 2026-05-29 | SANA Nov avg: -2.63% median: -13.55% win: 25% σ: 26.73% n: 4 2022-04-12 → 2026-05-29 | SANA Dec avg: -16.77% median: -13.10% win: 25% σ: 18.71% n: 4 2022-04-12 → 2026-05-29 |